Antipsychotics and Their Impact on Cerebral White Matter: Part of the Problem or Part of the Solution?
Am J Psychiatry
.
2018 Nov 1;175(11):1056-1057.
doi: 10.1176/appi.ajp.2018.18060752.
Authors
Marek Kubicki
1
,
Amanda E Lyall
1
Affiliation
1
From the Psychiatry Neuroimaging Laboratory, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston; and the Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston.
PMID:
30380938
DOI:
10.1176/appi.ajp.2018.18060752
No abstract available
Keywords:
Administration; Antipsychotics; Brain Imaging Techniques; Psychoradiology; Schizophrenia.
Publication types
Editorial
Comment
MeSH terms
Antipsychotic Agents*
Humans
Psychotic Disorders*
Schizophrenia*
White Matter*
Substances
Antipsychotic Agents
Grants and funding
K01 MH115247/MH/NIMH NIH HHS/United States
R03 MH110745/MH/NIMH NIH HHS/United States